ArticleFrontiers in medicine2023

Regulatory agilities impacting review timelines for Pfizer/BioNTech's BNT162b2 mRNA COVID-19 vaccine: a retrospective study.

Prisha Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.